Bezlotoxumab

Bezlotoxumab
Monoclonal antibody
Type	Whole antibody
Source	Human
Target	Clostridioides difficile toxin B
Clinical data
Trade names	Zinplava
AHFS/Drugs.com	Monograph
MedlinePlus	a617003
License data	US DailyMed: Bezlotoxumab;
Pregnancy; category	AU: B2;
Routes of; administration	Intravenous
ATC code	J06BC03 (WHO) ;
Legal status
Legal status	AU: S4 (Prescription only); UK: POM (Prescription only); US: ℞-only; EU: Rx-only;
Identifiers
CAS Number	1246264-45-8;
DrugBank	DB13140;
ChemSpider	none;
UNII	4H5YMK1H2E;
KEGG	D10453;
Chemical and physical data
Formula	C6464H9974N1726O2014S46
Molar mass	145565.72 g·mol−1

Bezlotoxumab, sold under the brand name Zinplava, is a human monoclonal antibody designed for the prevention of recurrence of Clostridioides difficile infections. Bezlotoxumab binds to Clostridioides difficile toxin B.